Immune thrombocytopenia is a well-known complication of both HIV and Hepatitis C virus infections. Management becomes challenging when a patient with HCV-HIV co-infection presents with severe thrombocytopenia. Adverse drug reactions and drug interactions has to be considered while choosing treatment options for such patients. We report such a case which illustrates the difficulty in managing severe thrombocytopenia in HCV-HIV co-infected patients where evidence based clinical decision making helped in choosing the right therapy for the patient.

Download full-text PDF

Source

Publication Analysis

Top Keywords

immune thrombocytopenia
8
severe thrombocytopenia
8
severe immune
4
thrombocytopenia
4
thrombocytopenia patient
4
patient hiv-hcv
4
hiv-hcv co-infection
4
co-infection challenges
4
challenges management
4
management immune
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!